Study Conduct

HealthCarePoint’s mRSI initiative reaches 10-year milestone

Wednesday, April 5, 2017

HealthCarePoint (HCP) has announced that the modified Rankin Scale (mRS) standards are now available to healthcare and clinical research professionals on every continent and in over 12 languages through the BlueCloud Education Network. The achievement marks a 10-year milestone for the company, which is working to standardize healthcare training and certification for healthcare professionals internationally. 

[Read More]

TransCelerate calls out pharmacovigilance operational challenges

Tuesday, April 4, 2017

TransCelerate BioPharma has added Pharmacovigilance to its portfolio, establishing two new global initiatives: 1.) Interpretation of Pharmacovigilance Regulations and 2.) Value of Safety Information Data Sources. Both initiatives aim to create solutions that will reduce resource inefficiencies, enhance information exchange with global health authorities and improve patient safety to drive more value for patients.

[Read More]

Collaborative definition of patient centricity by AstraZeneca, patients and carers

Friday, March 31, 2017

AstraZeneca has announced that BMJ Innovations has published the first collaborative definition of patient centricity for the pharmaceutical industry. The definition was co-developed with patients and caregivers using research led by AstraZeneca and patient community advocates to ensure a deep understanding of patient needs and values. Ten associated patient-centric principles were also identified and published in BMJ Innovations to provide the pharmaceutical industry with a consistent reference point to sustain meaningful and mutually beneficial engagement with patients. Wider testing of these outputs among U.S. and European patient communities confirmed their validity.

[Read More]

Icertis updates clinical trial agreement and budgeting solution

Wednesday, March 29, 2017

Icertis, a provider of enterprise contract management in the cloud, has announced an upgrade to the Icertis Clinical Trial Agreement and Budgeting solution designed to improve clinical trials contract management. Built on the Icertis Contract Management (ICM) platform, the solution speeds up clinical trial contracting while improving collaboration and compliance with CRO.

[Read More]

INC Research accelerates clinical trial startup with goBalto Activate

Wednesday, March 29, 2017

goBalto, a provider of cloud-based clinical study startup solutions, announced results from its ongoing partnership with INC Research, a global CRO and pioneer in the implementation of goBalto’s end-to-end study startup platform to accelerate delivery of phase I to IV clinical trials for global biopharmaceutical customers. INC Research continues to optimize its clinical study startup process on a worldwide basis, leveraging goBalto’s technology to start more than 220 studies in more than 68 countries to date.

[Read More]

NIH achieves milestone to accelerate multisite clinical studies

Friday, March 24, 2017

Developing new treatments for diseases often requires large numbers of clinical research participants enrolled in the same study at numerous geographical sites. These multisite clinical trials are well-positioned to discover whether a promising therapeutic is safe and effective, and may provide medical professionals with the information needed for treating their patients. However, the initiation of such studies may be delayed because each site typically relies on its own Institutional Review Boards (IRBs) to provide ethics reviews of the risks and benefits of the proposed research.

[Read More]

PPD launches apprenticeship for Clinical Research Associates

Thursday, March 23, 2017

Pharmaceutical Product Development (PPD) launched a clinical research associates (CRAs) apprenticeship program targeted to military veterans and military service members with medical backgrounds who are transitioning to the civilian workforce. PPD’s initiative, the first CRA apprenticeship program registered with the U.S. Department of Labor, will begin in North Carolina, Texas and California in the first quarter of this year.

[Read More]